OpenVSafe by OpenVAERS
Search V-safe

MA7-25299-69353

1 vaccination 5 coded responses 6 check-ins 5 free-text entries 5 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
160 / PA
Registered
2020-12-20
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-19
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-20
    Registered in v-safe
  3. 2020-12-20
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sore throat, sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-20
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Excessive sweating, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2020-12-21
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  7. 2020-12-22
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sweating, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2020-12-22
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2020-12-23
    Survey response — days 1–6 daily, dose 1
    MedDRA: Hyperhidrosis, Oropharyngeal pain — Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sore throat, sweating
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2020-12-23
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-01-05
    Health check-in — day 14, dose 1
    Feeling: Fair
    Adult check-in
  12. 2021-12-19
    Survey response — 12 months, dose 1
    MedDRA: Cardiac disorder, Migraine, Nasopharyngitis, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Frequent migraines, more susceptible to colds, frequent heart issues · Healthcare visit (other): Doctors office
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-12-19
    Report sent to call center — 12 months, dose 1
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  14. 2021-12-20

Vaccinations

DoseDateManufacturerCo-administered
12020-12-19Pfizer-BioNTech

Call center

5 call center cases

1 unsuccessful · 4 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-20

Systemic reaction (other): Sore throat, sweating

2020-12-21

Systemic reaction (other): Excessive sweating, sore throat

2020-12-22

Systemic reaction (other): Sweating, sore throat

2020-12-23

Systemic reaction (other): Sore throat, sweating

Release 10 — 12 months, dose 1

2021-12-19

Symptoms: Frequent migraines, more susceptible to colds, frequent heart issues
Healthcare visit (other): Doctors office

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDCardiac disorder · · ✓
SDMigraine · · ✓
SDNasopharyngitis · · ✓
SROHyperhidrosis ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release